{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:25Z","timestamp":1791576085725,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ)","award":["407540\/2012-1"],"award-info":[{"award-number":["407540\/2012-1"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["407540\/2012-1"],"award-info":[{"award-number":["407540\/2012-1"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Pesquisa Translacional em Sa\u00fade e Ambiente na Regi\u00e3o Amaz\u00f4nica (INCT-INPeTAm)"},{"DOI":"10.13039\/501100004933","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Toxinas (INCT-Tox)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004933","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Rond\u00f4nia (Funda\u00e7\u00e3o Rond\u00f4nia-FAPERO)","award":["01.1131.00033-0013\/2013"],"award-info":[{"award-number":["01.1131.00033-0013\/2013"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.intimp.2016.04.025","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T14:02:30Z","timestamp":1462802550000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Liposomes containing an ASP49-phospholipase A 2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis"],"prefix":"10.1016","volume":"36","author":[{"given":"Neuza B.","family":"de Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.A.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e1lia S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika P.","family":"Tagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando B.","family":"Zanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson M.","family":"Kayano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreimar M.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Nicolete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.04.025_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New world cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0010","unstructured":"World Health Organization. Leishmaniasis. http:\/\/www.who.int\/leishmaniasis\/ (10 janeiro 2015, date last accessed)."},{"issue":"Issue 6","key":"10.1016\/j.intimp.2016.04.025_bb0015","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000\u221211): a systematic assessment","volume":"Volume 1","author":"Pedrique","year":"2013","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.intimp.2016.04.025_bb0020","first-page":"47","article-title":"Atividade leishmanicida in vitro de Eugenia uniflora e Momordica charantia","volume":"34","author":"Santos","year":"2013","journal-title":"Rev. Ci\u00eanc. Farm. B\u00e1sica Apl."},{"key":"10.1016\/j.intimp.2016.04.025_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962007000200002","article-title":"Tratamento da Leishmaniose Tegumentar Americana","volume":"82","author":"Lima","year":"2007","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0030","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2016.04.025_bb0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiasis and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniais","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2016.04.025_bb0045","first-page":"15","article-title":"Nanoparticle-conjugated animal venom\u2013toxins and their possible therapeutic potential","volume":"3","author":"Biswas","year":"2012","journal-title":"J. Venom. Res."},{"key":"10.1016\/j.intimp.2016.04.025_bb0050","first-page":"371","article-title":"Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins","volume":"142","author":"St\u00e1beli","year":"2007","journal-title":"Comp. Biochem. Physiol. C"},{"key":"10.1016\/j.intimp.2016.04.025_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1022563401413","article-title":"The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity","volume":"17","author":"Pereira","year":"1998","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.intimp.2016.04.025_bb0060","first-page":"1","article-title":"Use of snake venom for biomedical researches and drug development","volume":"1","author":"Soares","year":"2012","journal-title":"Open J. Biochem. Biotechnol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxicon.2014.08.001","article-title":"Bothrops jararacussu snake venom-induces a local inflammatory response in a prostanoid- and neutrophil-dependent manner","volume":"90","author":"Wanderley","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2016.04.025_bb0070","first-page":"1343","article-title":"New delivery strategies for the old pentavalent antimonial drugs expert Opin","volume":"12","author":"Frezard","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2016.04.025_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijantimicag.2008.10.013","article-title":"N-(2-hydroxypropyl) methacrylamide\u2013amphotericin B (HPMA\u2013AmB) copolymer conjugates as antileishmanial agents","volume":"33","author":"Nicoletti","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.intimp.2016.04.025_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.exppara.2013.07.022","article-title":"Liposomal\u2013lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell","volume":"135","author":"Barros","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0085","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2016.04.025_bb0090","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/jcc.21797","article-title":"Fast docking using the CHARMM force field with EADock DSS","volume":"32","author":"Grosdidier","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.intimp.2016.04.025_bb0095","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.intimp.2016.04.025_bb0100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera \u2014 a visualization system for exploratory research and analysis","volume":"25","author":"Goddard","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.intimp.2016.04.025_bb0105","first-page":"4","volume":"3","author":"Olson","year":"2007","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.intimp.2016.04.025_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.actatropica.2004.03.007","article-title":"The leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages","volume":"91","author":"Silva-Jardim","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2016.04.025_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2016.04.025_bb0120","first-page":"591","article-title":"Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: insights into Ca(2+)-independent catalytic mechanism","volume":"2008","author":"Corr\u00eaa","year":"1784","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2016.04.025_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/prot.22858","article-title":"Structural, functional, and bioinformatics studies reveal a new snake venom homologue phospholipase A2 class","volume":"79","author":"Dos Santos","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.intimp.2016.04.025_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1021051831740","article-title":"Purification and amino acid sequence of MP-III 4R D49 phospholipase A2 from Bothrops pirajai snake venom, a toxin with moderate PLA2 and anticoagulant activities and high myotoxic activity","volume":"18","author":"Toyama","year":"1999","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.intimp.2016.04.025_bb0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0300-9084(00)01150-0","article-title":"Myotoxic phospholipases A2 in Bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu","volume":"82","author":"Andri\u00e3o-Escarso","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2016.04.025_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2010.10.016","article-title":"Quercetin as an inhibitor of snake venom secretory phospholipase A2","volume":"189","author":"Cotrim","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2016.04.025_bb0145","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2016.04.025_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxicon.2011.04.018","article-title":"Comparative study of the effects of venoms from five rear-fanged snake species on the growth of Leishmania major: identification of a protein with inhibitory activity against the parasite","volume":"58","author":"Peichoto","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2016.04.025_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"6","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2016.04.025_bb0160","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1098\/rstb.1997.0115","article-title":"Cytokines and nitric oxide as ejector moelecules againt parasitic infections","volume":"352","author":"Liew","year":"1997","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"key":"10.1016\/j.intimp.2016.04.025_bb0165","first-page":"570","article-title":"Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis","volume":"69","author":"Liew","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2016.04.025_bb0170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijpara.2010.03.011","article-title":"The role of TNF in parasitic diseases: still more questions than answers","volume":"40","author":"K\u00f6rner","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.intimp.2016.04.025_bb0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.toxicon.2006.02.001","article-title":"Importance of jararhagin desintegrin-like and cysteine-rich domains in the early events of local inflammatory response","volume":"47","author":"Clissa","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2016.04.025_bb0180","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"11","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2016.04.025_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000371391","article-title":"Biodegradable microparticles containing crotamine isolated from Crotalus durissus terrificus display antileishmanial activity in vitro","volume":"95","author":"Macedo","year":"2015","journal-title":"Pharmacology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916301606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916301606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T06:22:44Z","timestamp":1536733364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916301606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":37,"alternative-id":["S1567576916301606"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.04.025","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}